Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical, Inc. \De\ (LFCR) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 17 years, with Q2 2025 value amounting to -$8.3 million.

  • Lifecore Biomedical, Inc. \De\'s Enterprise Value rose 232.81% to -$8.3 million in Q2 2025 from the same period last year, while for May 2025 it was -$8.3 million, marking a year-over-year increase of 232.81%. This contributed to the annual value of -$8.3 million for FY2025, which is 232.81% up from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Enterprise Value stood at -$8.3 million for Q2 2025, which was up 232.81% from -$5.4 million recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s Enterprise Value's 5-year high stood at -$609000.0 during Q4 2021, with a 5-year trough of -$19.1 million in Q2 2023.
  • For the 5-year period, Lifecore Biomedical, Inc. \De\'s Enterprise Value averaged around -$4.9 million, with its median value being -$2.7 million (2022).
  • Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 7540.39% in 2021, then crashed by 182643.79% in 2023.
  • Lifecore Biomedical, Inc. \De\'s Enterprise Value (Quarter) stood at -$609000.0 in 2021, then crashed by 875.04% to -$5.9 million in 2022, then tumbled by 221.51% to -$19.1 million in 2023, then surged by 50.47% to -$9.5 million in 2024, then grew by 12.59% to -$8.3 million in 2025.
  • Its Enterprise Value stands at -$8.3 million for Q2 2025, versus -$5.4 million for Q1 2025 and -$9.5 million for Q4 2024.